Home » Clinical Trials »  Search Clinical Trials

Therapeutic Areas:  |  Neurology

Search Medical Condition
Please enter condition
Please choose location from dropdown

Memory Problems Clinical Trials

A listing of Memory Problems medical research trials actively recruiting patient volunteers. Search for closest city to find more detailed information on a research study in your area.

RESULTS

Found (54) clinical trials

The purpose of this study is to evaluate Donepezil and Memantine for the treatment of Alzheimer's disease.

Phase

SPRI is currently participating in a multi-center, 24-month clinical evaluation of an investigational drug for people suffering from mild cognitive impairment (MCI) or mild Alzheimer’s disease (AD).

Phase N/A

SPRI Clinical Trials of Brooklyn, under the sponsorship of Suven Life Sciences, is currently participating in the clinical evaluation of the safety and effectiveness of an investigational drug in persons with moderate dementia due to Alzheimer’s disease.

Phase

With age, some memory loss is normal. But it can also indicate the beginnings of Alzheimer’s. If you’ve noticed more forgetfulness and a decreased ability to function over the last year, you may be in the beginning stages of Alzheimer’s. If you have not been diagnosed and are between ages ...

Phase

This study will evaluate the effects of daily dosing of AC-1204 on cognition, activities of daily living, resource utilization, quality of life, pharmacokinetic measures and safety among participants with mild to moderate Alzheimer's Disease Inclusion Criteria: Dementia status of mild to moderate CT or MRI scan within 18 months prior ...

Phase

This is a Phase II, randomised, multi-centre, double-blind, placebo-controlled proof-of-concept study to assess the safety, tolerability and efficacy of oral Xanamem™ once daily in adult subjects with mild dementia due to AD.

Phase

The purpose of this study is to determine the safety and efficacy of TRx0237 8 mg/day in the treatment of subjects with mild Alzheimer's Disease compared to placebo.

Phase

Study Description: The purpose of this study is to test whether two investigational drugs called CAD106 and CNP520, administered separately, can slow down the onset and progression of clinical symptoms associated with Alzheimer's disease (AD) in participants at the risk to develop clinical symptoms based on their age and genotype. ...

Phase

Multi-center, randomized, double-blind, parallel-group,placebo-controlled study to evaluate the safety and tolerability, efficacy, and PK of 60 mg and 90 mg AD-35 administered QD during 6 months of double-blind treatment followed by a second 6 months of open-label treatment to subjects with mild to moderate AD.  

Phase

Effects of Music and Dance on Cognition Frailty and Burden in Elderly Caregivers Living in Rural Communities

Sample Variables above described of 58 participants will be measured. The participants will be randomized to the dance group (experimental) and to the health care guidance group (control). The group will be paired by age, sex, and schooling. This study focused on prevention of cognitive performance decline, frailty and burden.

Phase N/A